LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (NASDAQ: CBRX) announced today that an interim analysis of a pregnancy study comparing the efficacy of CRINONE® 8% (progesterone gel) to compounded intramuscular progesterone (IMP) injections is now available online and will be published in Fertility and Sterility, the journal of the American Society for Reproductive Medicine (ASRM).
